HYDERABAD: The Environment Protection and Training Research Institute (EPTRI) took on the CSIR Scientists Service Forum accusing it of being `antidevelopment' in its stance on the Hyderabad Pharma
The United States is pressing India not to extend price caps on medical devices and wants New Delhi to allow firms to withdraw products from the market if they do not wish to sell at government det
This global report maps 39 dimensions of country risk that are material to the private sector, using globally comparable datasets produced by international institutions.
This massive industrial park is expected to create jobs for 1.5 million people once fully developed
After years of constant denial, it appears that in the draft policy, the government is finally ready to accept that there is a problem with the drugs that are manufactured and sold in India.
CHENNAI: Pharmaceutical major Strides Shasun, which has secured the US Food and Drug Administration’s approval for its three plants in Puducherry and Cuddalore, is facing trouble.
Price control of Oral Rehydration Salt (ORS), a life-saving intervention for diarrhoea, is mired in controversy as the company with the largest share in the ORS market has challenged the ceiling pr
Order of the National Green Tribunal in the matter of Selaqui International School Vs. Union of India & Others dated 25/07/2017 regarding discharge of toxic waste by the factories at the Pharma City, Selaqui, Dehradun into River Yamuna.
CHENNAI: A shortage of drugs has affected the state since July 1 when the Goods and Services Tax (GST) kicked in, with dealers and distributors uncertain over the taxation structure and facing soft
National Institute of Virology to receive Sun Pharma's drug molecules for testing against 3 diseases
Forfeiting our commons
The Lancet’s Series on Maternal and Child Undernutrition
President Obama's grand climate plan does not add up
Climate change can no longer be ignored
NGO demands withdrawal of Niyamgiri gram sabha notificatio